[HTML][HTML] The effect of convalescent plasma therapy on mortality among patients with COVID-19: systematic review and meta-analysis
To determine the effect of COVID-19 convalescent plasma on mortality, we aggregated
patient outcome data from 10 randomized clinical trials, 20 matched control studies, 2 dose …
patient outcome data from 10 randomized clinical trials, 20 matched control studies, 2 dose …
[HTML][HTML] Convalescent plasma for the prevention and treatment of COVID-19: a systematic review and quantitative analysis
Background: The COVID-19 pandemic, caused by a novel coronavirus termed SARS-CoV-2,
has spread quickly worldwide. Convalescent plasma (CP) obtained from patients following …
has spread quickly worldwide. Convalescent plasma (CP) obtained from patients following …
Modalities and mechanisms of treatment for coronavirus disease 2019
Z Zuo, T Wu, L Pan, C Zuo, Y Hu, X Luo… - Frontiers in …, 2021 - frontiersin.org
Coronavirus disease 2019 (COVID-19), which is caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), is spreading rapidly throughout the world. Although …
syndrome coronavirus 2 (SARS-CoV-2), is spreading rapidly throughout the world. Although …
Passive immunity should and will work for COVID-19 for some patients
N Cimolai - Clinical Hematology International, 2021 - Springer
In the absence of effective antiviral chemotherapy and still in the context of emerging
vaccines for severe acute respiratory syndrome-CoV-2 infections, passive immunotherapy …
vaccines for severe acute respiratory syndrome-CoV-2 infections, passive immunotherapy …
Modalities and Mechanisms of Treatment for Coronavirus
Z Zuo, T Wu, L Pan, C Zuo, Y Hu, X Luo… - … for COVID-19 …, 2021 - books.google.com
Zuo Z, Wu T, Pan L, Zuo C, Hu Y, Luo X, Jiang L, Xia Z, Xiao X, Liu J, Ye M and Deng M
(2021) Modalities and Mechanisms of Treatment for Coronavirus Disease 2019. Front …
(2021) Modalities and Mechanisms of Treatment for Coronavirus Disease 2019. Front …
What's new in critical illness and injury science? Convalescent plasma for coronavirus disease-2019 patients with severe or critical illness
AC Miller, S Ghadermarzi… - International Journal of …, 2021 - journals.lww.com
Since emerging in December 2019, the coronavirus disease‑2019 (COVID‑19) pandemic
caused by the beta‑coronavirus severe acute respiratory syndrome‑related coronavirus‑2 …
caused by the beta‑coronavirus severe acute respiratory syndrome‑related coronavirus‑2 …
VITAM in COVID 19: A Systematic Approach to a Global Pandemic
SNS Yarrarapu, P Bansal… - Clinical Medicine …, 2021 - journals.sagepub.com
Introduction In the unprecedented era of COVID-19, ongoing research and evolution of
evidence has led to ever-changing guidelines for clinical monitoring and therapeutic …
evidence has led to ever-changing guidelines for clinical monitoring and therapeutic …
Comparison of hematological and biochemical parameters in COVID-19 pneumonia patients before and after convalescent plasma (CP) treatment: COVID-19 …
Background/Aim: Convalescent plasma (CP) therapy, which includes processing and
administering antibody-rich plasma from recovered patients to sick patients, is used for …
administering antibody-rich plasma from recovered patients to sick patients, is used for …